618 filings
Page 11 of 31
8-K
uu6cp2o ftmx6cm04ii5
3 Mar 20
Other Events
10:00am
8-K
6iuxe8h
2 Mar 20
Other Events
11:14am
8-K
8qufvm poy
15 Jan 20
Other Events
6:05am
8-K
lnhzuglw570rtz
10 Jan 20
VBI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac® Meets Primary and Secondary Endpoints
3:23pm
8-K
gfdz708ni8yt3s
22 Nov 19
Other Events
8:11am
8-K
2r0n ej79ac
14 Nov 19
Other Events
4:54pm
8-K
vgklhjjsqz
12 Nov 19
VBI Vaccines to Present Initial Phase 1/2a Part B Data of VBI-1901 at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
6:15am
8-K
jg6d0382bnoe
6 Nov 19
VBI Vaccines Announces Third Quarter 2019 Financial Results and Provides Corporate Update
8:51am
8-K
8u888kzgeo dq5h
25 Oct 19
VBI Vaccines to Present New Immuno-Oncology Data at the World Vaccine Congress Europe 2019
12:00am
8-K
d7x i5cmcn
23 Oct 19
VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver Meeting® 2019
6:05am
8-K
rz7bb6 93bw
2 Oct 19
Other Events
9:00am
8-K
45ahx
26 Sep 19
VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:05am
424B5
bax8u8h23w
20 Sep 19
Prospectus supplement for primary offering
5:28pm
8-K
dea osra3
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
424B5
7do0b0x93v5n3t
18 Sep 19
Prospectus supplement for primary offering
4:04pm
8-K
jy4371f 5hin2d
10 Sep 19
Regulation FD Disclosure
8:00am
8-K
1alsj 8o355wf
5 Sep 19
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
4:30pm
8-K
g7vyiv32k14nwmij
16 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am